HVTN 702 was a clinical trial which the HIV Vaccine Trials Network organized to develop an HIV vaccine.
In February 2020 the organizers halted the trial after finding no evidence of efficacy.
[1][2][3] Around December 2019 various media outlets reported that HVTN 702 could be an effective vaccine in preventing HIV.
[4][5] In 2016 various media outlets announced the start of the research.
[6][7][8] HVTN 702 was based on outcomes of the RV 144 trial.